With reference to the Increase in Price, Samrat Pharmachem Ltd has Clarified to BSE that :

"In this connection, we would like to inform you that Company has not made any big announcement having impact on its operation and performance in recent times.

The Company has been sharing all information/ announcements that have a bearing on the price/ volume behavior in the script with the stock exchange regularly.

The reason for the increase in the price of share on the BSE is not result of any announcement or pending announcement made or to be made by the company.

The Company has not shared any price sensitive information with any market intermediary or any other party and therefore the rise in the price of the shares on the BSE is not known to the Company.

We have been strictly following all the listing norms for disclosure, insider trading with the stock exchanges regularly and there is no pending compliance on our part."

Source : BSE - >

Published on March 18, 2015


This article is closed for comments.
Please Email the Editor